These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38860736)

  • 1. Pulmonary artery pseudoaneurysm due to COVID-19-associated pulmonary mucormycosis.
    Li Z; Zhang H; Liu Z
    Eur Heart J; 2024 Aug; 45(31):2896. PubMed ID: 38860736
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary Artery Pseudoaneurysm Caused by Pulmonary Mucormycosis.
    Zhang M; Luo Q; Li X; Mu X; Wu W
    Am J Respir Crit Care Med; 2024 Apr; 209(7):879-880. PubMed ID: 38306668
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudoaneurysm of the pulmonary artery with massive haemoptysis due to an invasive pulmonary mucormycosis.
    Lopez-Pastorini A; Koryllos A; Brockmann M; Windisch W; Stoelben E
    Thorax; 2016 Feb; 71(2):199-200. PubMed ID: 26385775
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasive pulmonary mucormycosis with concomitant lung cancer presented with massive hemoptysis by huge pseudoaneurysm of pulmonary artery.
    Kim YI; Kang HC; Lee HS; Choi JS; Seo KH; Kim YH; Na J
    Ann Thorac Surg; 2014 Nov; 98(5):1832-5. PubMed ID: 25441799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary mucormycosis with ruptured pseudoaneurysm.
    Merlino J; Temes RT; Joste NE; Gill IS
    Ann Thorac Surg; 2003 Apr; 75(4):1332. PubMed ID: 12683595
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
    Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
    Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient with myelodyplastic syndrome, pulmonary nodules, and worsening infiltrates.
    Wohlrab JL; Anderson ED; Read CA
    Chest; 2001 Sep; 120(3):1014-7. PubMed ID: 11555540
    [No Abstract]   [Full Text] [Related]  

  • 8. Cavitary pulmonary opacity in a diabetic patient.
    Wu BR; Li CH; Chen CH
    Intern Med; 2012; 51(15):2061-2. PubMed ID: 22864139
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary mucormycosis with few symptoms in a patient with lung cancer].
    Ramón MM; Císcar MA; Peris R; Alemany P; Arnau A; Juan G
    Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):43-4. PubMed ID: 8155759
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucormycotic Pulmonary Pseudoaneurysm Causing Fatal Hemoptysis.
    Souza LVS; Souza AS; Marchiori E
    Arch Bronconeumol (Engl Ed); 2019 Nov; 55(11):597-598. PubMed ID: 31113670
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality.
    Muthu V; Agarwal R; Chakrabarti A
    Mycopathologia; 2022 Aug; 187(4):405-406. PubMed ID: 35690964
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapidly Progressing Rhino-orbito-cerebral Mucormycosis with Concomitant Pulmonary Mucormycosis in a Post-COVID-19 Diabetic Subject.
    Dhawan VB; Manoj M
    Indian J Public Health; 2024 Jan; 68(1):137-139. PubMed ID: 38847641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous emphysema of the chest: could it be pulmonary mucormycosis?
    Koshy CG; Shah S; Mammen T
    Thorax; 2010 Mar; 65(3):280. PubMed ID: 20335307
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary mucormycosis.
    Chauhan BR; Gupta DK; Kaushal SS; Pal LS; Nada R
    J Assoc Physicians India; 1998 Apr; 46(4):396-7. PubMed ID: 11273329
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary mucormycosis as a presentation of COVID 19: Case series.
    Kaur N; Kaur A; Singh P; Kaur H; Peer S; Sahoo SS
    Indian J Tuberc; 2024 Jul; 71(3):366-369. PubMed ID: 39111949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary mucormycosis in a patient with uncontrolled diabetes.
    Souza LVS; Souza AS; Zanetti G; Marchiori E
    Rev Soc Bras Med Trop; 2024; 57():e009172024. PubMed ID: 38896656
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary mucormycosis diagnosed by bronchoalveolar lavage: a case report and review of the literature.
    al-Abbadi MA; Russo K; Wilkinson EJ
    Pediatr Pulmonol; 1997 Mar; 23(3):222-5. PubMed ID: 9094732
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary mucormycosis presenting as an endobronchial lesion.
    Husari AW; Jensen WA; Kirsch CM; Campagna AC; Kagawa FT; Hamed KA; Azzi RL; Stevens DA
    Chest; 1994 Dec; 106(6):1889-91. PubMed ID: 7988219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary mucormycosis with massive fatal hemoptysis.
    Murray HW
    Chest; 1975 Jul; 68(1):65-8. PubMed ID: 1149533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary mucormycosis in the setting of chronic obstructive pulmonary disease. A case report and review of the literature.
    Spira A; Brecher S; Karlinsky J
    Respiration; 2002; 69(6):560-3. PubMed ID: 12457013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.